IP Verse

Inflammatory Disease Treatment With Complement Inhibitors

Patent No. EP3980047 (titled "Inflammatory Disease Treatment With Complement Inhibitors") was filed by RA Pharmaceuticals on Jun 4, 2020. The application was issued on Feb 14, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KRAUSSNov 11, 2024KRAUSS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3980047

RA PHARMACEUTICALS
Application Number
EP20749996A
Filing Date
Jun 4, 2020
Status
Granted And Under Opposition
Jan 12, 2024
Publication Date
Feb 14, 2024
External Links
Slate, Register , Google Patents